Delivery Order SPE2DB20D1004-SPE2DB25FNECD
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FB2K1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,931.95 award is for the delivery of 4564259891 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with an ultimate completion date of April 15, 2024. This is a firm fixed price delivery order contract, with no set-aside designation.
Amerisourcebergen Drug Corp also...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FU09P, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,368.05 firm fixed-price delivery order is for the supply of 4564544064 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of May 9, 2024.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $9,215.03 for the supply of 4564591018 CONTRAVE ER 8-90 MG TABLET 120S. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier of medical products to the U.S. government. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6JQC, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. The award has a firm fixed price of $4,754.30 and a period of performance through March 25, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $3,876.18 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a period of performance through September 19, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. government. The contract, valued at up to $2,558.43, is for the delivery of 4564666722 CONTRAVE ER 8-90 MG TABLET 120S. This is a Firm Fixed Price Delivery Order contract with a completion date of May 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,701.93 fixed-price delivery order is for the supply of 4564557610 - CONTRAVE ER 8-90 MG TABLET 120S, with a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 mg tablets in quantities of 120 per container. The contract has a ceiling value of $17,368.57 and spans from the award date of September 25, 2024 through the ultimate completion date of September 26, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award, valued at $23,699.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a ceiling value of $8,152.21 and an ultimate completion date of May 30, 2024. It is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...